Legend Biotech Corp (LEGN)
Legend Biotech Corp (LEGN) is a Healthcare stock tracked by StreetAlpha. LEGN reports earnings on Wed, Nov 11, 2026. The average 12-month price target from 7 analysts is $46.29, with a high of $74.00 and a low of $24.00. Analyst consensus is Buy, based on the latest ratings from 7 firms (4 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in LEGN, 0% of them bullish and 100% bearish. In the past 30 days there were 1 dark pool print totaling $1.4M, the largest $1.4M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 7 analysts who set a price target on LEGN in the past 90 days. The average target is $46.29, with a high of $74.00 and a low of $24.00.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 11 | Barclays | Maintained | Buy | $74 |
| Aug 12 | TD Cowen | Maintained | Hold | $24 |
| Aug 12 | Oppenheimer | Downgrade | Buy | $40 |
| Aug 12 | RBC Capital | Target lowered | Buy | $59 → $58 |
| Aug 12 | Barclays | Maintained | Buy | $78 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LEGN is in one of them and how their past LEGN trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered LEGN in an article yet. Here's the latest on the wider market.
For informational purposes only. Not financial advice. Options flow and dark pool data are delayed and may be incomplete.